Adipo Pharma (private company)
See something wrong or missing? Let us know
Offices:Strasbourg
Industry:BiotechManufacturingPharma
Business model:B2B
AdipoPharma SAS is a biotech company from France developing a novel and promising type 2 diabetes drug as it leverages adipocyte for the treatment of insulin resistance, type 2 diabetes and related disorders.
Investors:
we tracked 2 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Adipo Pharma
Name | Criteria | |
---|---|---|
![]() |
Octarine Bio
57%
|
|
![]() |
Cytoki Pharma
57%
|
|
![]() |
Alginor
57%
|
|
![]() |
Exciva
57%
|
|
![]() |
Mytos
57%
|
|
![]() |
Emergence Therapeutics
57%
|
|
![]() |
Oncorena
57%
|
|
![]() |
Precirix
57%
|
|
![]() |
Kither Biotech
57%
|
|
![]() |
InnoSIGN
57%
|
|